N/A N=63 China 3T MRI Study
Bradycardia · Tachycardia · Heart Failure
Primary: The Occurrence of an MRI-related Event for CIED — 59; 0 Participants — p=0.002
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=47 Evaluation of the Course and Effectiveness of Conservative Therapy in Patients With Achilles Tendinopathy
Achilles Tendinopathy
Primary: Peak Spatial Frequency Radius at the Site of Pathology — 2.180; 2.146; 2.194; 2.184 mm^-1
Phase 2 N=160 A Study of Cytisinicline for Vaping Cessation in Adult Smokers
Vaping · E-Cig Use
Primary: Percentage of Participants With Vaping Abstinence From Week 9 to 12 — 15.1; 31.8 percentage of participants — p=0.0350
Phase 2 N=56 Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure
Primary Open Angle Glaucoma · Ocular Hypertension
Primary: Change From Baseline in Ocular Hypertension as Measured by Intraocular Pressure (IOP) — -1.985; -1.118; -0.827 Change in IOP mmHg
N/A N=100 Self-Control in Bulimia Nervosa
Bulimia Nervosa
Primary: Brain Activation Associated With P(Stop) — 0.02; 0.11; 0.04; 0.05 BOLD Signal
N/A N=33 Safety and Performance of Short- and Long-term Baseplates for Attaching the UNEEG Episight Recorder - Part I
Healthy Subjects
Primary: Trans Epidermal Water Loss (TEWL) to Measure Skin-friendliness — 20.7; 8.0; 19.3; 8.0 g/m²/h
Phase 4 N=182 Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye.
Dry Eye
Primary: Change in Ocular Surface Disease Index (OSDI) — 26.4; 26.3; 26.6; 16.4 score on a scale
Phase 2 N=24 A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)
Autoimmune Hepatitis
Primary: Patients Who Achieved Complete Biochemical Response — 6; 3; 7; 3 Participants
N/A N=200 Women's Treatment and Early Recovery
Substance-related Disorders
Primary: Treatment Completion — 43; 31 Number of women — p=<0.05
N/A N=14 SCI Acute Intermittent Hypoxia and Non-Invasive Spinal Stimulation Combined With Gait Training
Spinal Cord Injuries · Spinal Cord Diseases
Primary: Change in 6 Minute Walk Test — 19.57; 12.28; 9.63; 19.03 meters (m)
Phase 4 N=79 A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty
Central Precocious Puberty
Primary: Percentage of Participants With Peak Luteinizing Hormone (LH) Suppression in Gonadotropin-Releasing Hormone (GnRH) Stimulation at Week 24 — 97.47 percentage of…
Phase 2 N=17 Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Primary Mediastinal (Thymic) Large B-Cell Lymphoma · Recurrent Aggressive Non-Hodgkin Lymphoma · Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma
Primary: Overall Response Rate of Pembrolizumab With Concurrent Fractionated External Beam Radiotherapy (EBRT) Among Patients With Relapsed and Refractory Non-Hodgkin Lymphoma…
Phase 2 N=6 Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients
Liver Transplantation
Primary: Regulatory T-Cell Count — 0.44; 3.71; 3.57; 0.6 percentage of PBMC — p=< 0.01
N/A N=39 Evaluation of a New mHealth Tympanometer
Hearing Loss
Primary: Classification Agreement Between Prototype mHealth Tympanometer and Commercial Tympanometer — 93.33 Percent Agreement
Phase 1 N=48 Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)
Anesthesia; Adverse Effect · Cardiac Arrhythmia
Primary: Change-from-baseline in QTc Interval — 2.1; 5.1; -0.1; 4.1 ms — p=<0.05